Latest News
- UCLA joins the National Comprehensive Cancer Network to advance patient care, research and education
Two UCLA researchers have received a $2.7 million grant from the National Cancer Institute to develop new techniques to improve the quality of prostate magnetic resonance imaging and new artificial intelligence methods that use prostate MRI to assist cancer diagnosis.
March 24, 2020 9:30 AM
detail - Scientists awarded $2.7 million to study how AI can improve cancer diagnosis
Two UCLA researchers have received a $2.7 million grant from the National Cancer Institute to develop new techniques to improve the quality of prostate magnetic resonance imaging and new artificial intelligence methods that use prostate MRI to assist cancer diagnosis.
March 16, 2020 1:00 PM
detail - Cancer and COVID-19: What you should know
The number of COVID-19 cases are expected to continue to grow across the globe in the upcoming months and that means more people will have to take extra measures to help protect themselves and reduce the transmission of the disease.
March 13, 2020 6:00 AM
detail - Postdoctoral fellow chosen for CRI grant to pursue cutting-edge cancer research
The Cancer Research Institute (CRI) has named Katie Campbell, PhD, a postdoctoral fellow at the UCLA Jonsson Comprehensive Cancer Center, as the organization’s 2020 Irvington postdoctoral fellow.
March 03, 2020 11:30 AM
detail - Biochemist chosen for endowed professorship of molecular biology and biophysics
Keriann Backus has been selected for the Alexander and Renee Kolin Endowed Professorship of Molecular Biology and Biophysics.
March 02, 2020 8:00 AM
detail - Cancer researcher awarded fellowship for studying immunotherapy
Cristina Puig Saus, an associate project scientist in hematology/oncology at the David Geffen School of Medicine at UCLA, has been named a Parker Senior Fellow.
March 02, 2020 6:00 AM
detail - UCLA researchers discover new compound that promotes lung health
A molecule identified by UCLA researchers helps maintain a healthy balance of cells in airway and lung tissue. If the compound, so far only studied in isolated human and mouse cells, has the same effect in people, it may lead to new drugs to treat or prevent lung cancer.
February 18, 2020 8:00 AM
detail - Much shorter radiation treatment found to be safe, effective for people with soft tissue sarcoma
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center found that treating soft tissue sarcoma with radiation over a significantly shorter period of time is safe, and likely just as effective, as a much longer conventional course of treatment.
February 13, 2020 8:00 AM
detail - Unprecedented exploration generates most comprehensive map of cancer genomes charted to date
An international team has completed the most comprehensive study of whole cancer genomes to date, significantly improving our fundamental understanding of cancer and signposting new directions for its diagnosis and treatment.
February 07, 2020 8:00 AM
detail - Cold plasma patch could make immunotherapy more effective for treating melanoma, study finds
An interdisciplinary team of researchers at the UCLA Jonsson Comprehensive Cancer Center has developed a medicated patch that can deliver immune checkpoint inhibitors and cold plasma directly to tumors to help boost the immune response and kill cancer cells.
February 06, 2020 8:00 AM
detail - Botanical drug is shown to help patients with head and neck cancers
In a UCLA-led phase I clinical trial, a new plant-based drug called APG-157 showed signs of helping patients fight oral and oropharyngeal cancers.
February 05, 2020 8:00 AM
detail - Kidney Cancer Program receives $100,000 gift for research on genetic forms of kidney cancer
UCLA Health’s Kidney Cancer Program received $102,483 from Driven to Cure, a nonprofit organization dedicated to advocacy and providing funding for research on rare genetic forms of kidney cancer.
February 04, 2020 6:00 AM
detail - Researchers identify possible new combination treatment for advanced melanoma
A study by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusion of anti-tumor immune cells, or T cells, may produce a stronger immune response that could help fight advanced melanoma.
January 31, 2020 9:00 AM
detail - $18 million gift will expand whole-person care for patients and families facing cancer
An $18 million commitment from the Simms/Mann Family Foundation, led by Dr. Victoria Mann Simms and Ronald Simms, will support UCLA’s expansion of integrative psychosocial care for people with cancer and their families into communities throughout Southern California.
January 30, 2020 8:00 AM
detail - Nine years free of cervical cancer
In 2011, Grace Geaga was diagnosed with cervical cancer. In this video, learn how she credits UCLA Health’s Dr. Sanaz Memarzadeh with saving her life
January 29, 2020 12:00 PM
detail - UCLA researchers find chronic inflammation contributes to cancer metastasis
UCLA researchers have found that chronic exposure to interleukin-1-beta can promote lung cancer metastasis through inheritable changes of gene expression without altering DNA sequence
January 29, 2020 10:30 AM
detail - Scientist awarded $200,000 for pediatric bone sarcoma research
Alice Soragni has received a $200,000 grant from the Alex Lemonade Stand Foundation to support her work on single-cell profiling of pediatric bone sarcomas.
January 24, 2020 8:00 AM
detail - Researchers create framework for evaluating how fast a cancer will grow
An international team of researchers led by UCLA’s Paul Boutros have created a new way to accurately estimate how fast an individual cancer is evolving using open-source software.
January 10, 2020 6:00 AM
detail